Sperm Count & Quality
Semen Analysis, Population Decline, and the Parameters of Male Fertility
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (diagnostic topic)
Reference only. Not medical advice.
What can go wrong
Semen analysis describes a probability of fertility, not a binary diagnosis: men with parameters below reference limits can conceive, and men above them can be infertile. A single abnormal result should not be treated as definitive. The reported population decline, while consistently reproduced, is debated on methodological grounds (changing counting methods, lab standardization, selection of study populations over five decades). The clinical meaning of the trend for any individual man remains uncertain.
This is something to take to a clinician. The Atlas can tell you what is known about sperm count & quality in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Sperm count and quality are measured by semen analysis, the cornerstone of male fertility evaluation. The flagship evidence here is Levine et al. (Human Reproduction Update, 2017), a meta-analysis of 185 studies and 42,935 men reporting a 52.4% decline in sperm concentration among men from North America, Europe, Australia and New Zealand between 1973 and 2011. A 2023 update by the same group (223 studies, 53 countries) extended the trend to 2018 and reported acceleration. The proposed causes overlap substantially with those implicated in falling testosterone: endocrine-disrupting chemicals, obesity, heat exposure, sedentary lifestyle, and smoking.
The most-cited evidence that something is changing in male reproductive biology.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
A standard semen analysis assesses volume, sperm concentration, total sperm number, total and progressive motility, morphology (normal forms), vitality, pH, and the presence of leukocytes. The World Health Organization sets percentile-based reference limits (5th percentile of fertile men), revised in the 2021 sixth edition; values below these limits indicate reduced probability of conception but are not strict thresholds for sterility. Because sperm parameters vary widely within an individual, at least two analyses 2-4 weeks apart after 2-7 days of abstinence are recommended before drawing conclusions.
What it does to fertility
This entry is the fertility baseline for the entire category. Falling sperm concentration directly reduces the probability of natural conception per cycle and increases reliance on assisted reproduction. Critically, several causes of impaired sperm quality (obesity, endocrine disruptors, sedentary heat exposure) are the same factors associated with declining testosterone, and exogenous testosterone therapy itself suppresses spermatogenesis (see mf-trt-conflict). A man optimizing testosterone should understand that some interventions trade against his fertility.
What people get wrong
Often saidA low sperm count means a man is sterile
ActuallyReference limits are percentiles of fertile men, not sterility thresholds. Many men with counts below the limits father children naturally; conception probability is reduced, not abolished.
Often saidThe sperm decline is settled fact for every population
ActuallyThe Western decline is robustly reproduced, but data from South America, Asia and Africa are sparse, and critics cite changing lab methods over 50 years. The trend is real in the studied populations; its universality and individual meaning remain debated.
Often saidAt-home sperm tests replace a clinical evaluation
ActuallyDirect-to-consumer kits typically measure concentration or motile count only and miss morphology, vitality, and the clinical context. They screen; they do not diagnose.
Who profits, and who pushes back
Critics of the population-decline thesis
Caution that changing measurement methods, lab counting standards, selection of study populations, and geographic coverage may inflate or confound the apparent secular decline.
Authors of the WHO sixth-edition critique
Note the 2021 reference limits derive from a limited set of fertile-population cohorts and warn against treating the 5th-percentile values as diagnostic thresholds for infertility.
Sperm-count skeptics
Argue concentration alone is a weak predictor of conception and that DNA fragmentation and functional assays may matter more than raw counts.
How we got here
Concern about declining male fertility entered mainstream science with Carlsen and colleagues' 1992 BMJ meta-analysis, which pooled 61 studies and suggested sperm counts had roughly halved over half a century. The finding was contested for a decade on grounds of geographic bias and methodology. Hagai Levine, Shanna Swan and colleagues addressed many criticisms in their 2017 Human Reproduction Update meta-analysis, using meta-regression, controlling for confounders, and restricting the steepest claims to Western fertile and unselected populations. Their 2023 update broadened the geographic scope and reported the decline continuing and possibly accelerating. The work fueled both genuine scientific investigation into endocrine disruptors and a wave of commercial fertility-testing and supplement marketing.
- 1992Carlsen et al. BMJ meta-analysis first suggests historical sperm decline
- 2000sWHO updates semen reference values; debate over methodology continues
- 2010WHO 5th edition lowers reference limits using fertile-men percentiles
- 2017Levine et al. report 52.4% Western decline 1973-2011
- 2021WHO 6th edition revises reference limits again
- 2023Levine et al. update reports continued, accelerating decline
The people taking it
Semen analysis is the universal first-line male fertility test worldwide, performed in andrology and IVF laboratories. WHO reference values provide international standardization, though many labs still use older editions, complicating comparison. Direct-to-consumer mail-in testing has expanded access in North America and Europe while raising concerns about interpretation without clinical support.
Set against the alternatives
Conventional semen analysis remains the inexpensive, standardized first-line test, but it characterizes a population probability of conception rather than an individual's fertility. Compared with newer assays, it is less informative than sperm DNA-fragmentation testing for some idiopathic or recurrent-loss cases, and it cannot assess fertilization capacity the way functional or genetic tests can. Yet no single advanced test has displaced it: the WHO-standardized analysis is the reference against which alternatives are validated, and abnormal results typically trigger repeat testing and endocrine or genetic workup rather than a definitive verdict.
| Parameter | WHO 2021 lower limit | What it means | Caveat |
|---|---|---|---|
| Semen volume | >=1.4 mL | Fluid per ejaculate | Abstinence-dependent |
| Concentration | >=16 million/mL | Sperm density | Not a sterility cutoff |
| Total sperm number | >=39 million | Count per ejaculate | Volume x concentration |
| Total motility | >=42% | Any movement | Time-sensitive measure |
| Progressive motility | >=30% | Forward movement | Best fertility correlate |
| Normal morphology | >=4% | Strict normal forms | Often misread as failing |
| Vitality | >=54% | Live sperm fraction | Distinguishes dead vs immotile |
What we do not know
- Is the reported global sperm-concentration decline a true biological trend or partly a measurement and sampling artifact?
- Which environmental exposures (endocrine disruptors, heat, microplastics) are causal versus merely correlated?
- Do the 2021 WHO reference limits predict real-world conception better than the prior thresholds?
- How much does sperm DNA fragmentation add to conventional parameters for predicting outcomes?
- Can lifestyle or pharmacologic intervention reverse declining parameters at the population level?
What could change
DNA fragmentationWider clinical use of sperm DNA-integrity assays alongside standard parametersAt-home and AI analysisSmartphone and machine-vision sperm analysis aiming to standardize and democratize testingMicrofluidic selectionLab-on-chip sorting of high-quality sperm for assisted reproductionExposure biomarkersLinking endocrine-disruptor and oxidative-stress markers to individual semen quality
At a glance
- Flagship meta-analysis
- Levine et al. 2017, 185 studies
- Reported decline
- 52.4% sperm concentration, 1973-2011 (Western)
- Men analyzed
- 42,935
- WHO 2021 reference, concentration
- >=16 million/mL
- WHO 2021 reference, total count
- >=39 million per ejaculate
- WHO 2021 reference, motility
- >=42% total motile
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Sperm Count & Quality. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Levine et al., Human Reproduction Update (flagship)2017
Meta-regression of 185 studies (42,935 men): 52.4% decline in sperm concentration and 59.3% decline in total sperm count among Western men, 1973-2011; no significant decline detected in South America, Asia, and Africa (fewer studies)
Levine et al. update, Human Reproduction Update2023
Extended dataset to 2018 across 223 studies from 53 countries; reported continued decline and a steeper post-2000 slope, suggesting acceleration rather than plateau
WHO laboratory manual, 6th edition2021
Revised percentile-based reference limits; lowered concentration threshold to 16 million/mL from the 2010 value of 15 million/mL
Carlsen et al., BMJ1992
Original meta-analysis of 61 studies first suggesting a decline in sperm quality over 1938-1990, prompting decades of follow-up work